跳至主要内容
临床试验/NCT02665546
NCT02665546已完成不适用

Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

InCor Heart Institute1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
Maximal O2 uptake capacity (VO2 max)

研究概览

简要总结

Pulmonary Langerhans Histiocytosis Cells (PLCH) is characterized by infiltration of Langerhans cells and formation of loose granulomas with lymphocytic infiltrate and formation of nodular and cystic lesions on chest CT, and is often associated with smoking. Functionally, there may be obstructive and / or restrictive defect, with reduced carbon monoxide diffusing capacity. Dyspnea and lower exercise tolerance are common in PLCH, but exercise capacity in this disease is poorly understood and has not been compared to controls. Besides, the mechanisms involved in limiting exercise are poorly understood and cover multiple factors such as change in gas exchange, pulmonary hypertension (PH), dynamic hyperinflation, physical deconditioning and left heart failure. The involvement of pulmonary circulation in PLCH has unknown prevalence, but contributes to the symptoms. In the PH classification, PLCH belongs to the group 5, of multifactorial etiology. The definition of the presence and contribution of dyspnea mechanisms in different severities of PLCH is important to understanding the disease and individualization of treatment. The objective of the study is to evaluate the exercise capacity of patients with HCLP, and determinate mechanisms of dyspnea and lower exercise tolerance beyond its impact on quality of life.

详细描述

Langerhans cells are antigen-presenting cells of monocyte-macrophage lineage present in various epithelium like airways. Langerhans cell histiocytosis (LCH), also called histiocytosis X or pulmonary eosinophilic granulomatosis, are characterized by proliferation and infiltration of Langerhans cells in the affected organs, including skin, lung, bones, pituitary gland, liver, lymph nodes and thyroid gland.

Several clinical presentations have been described. In the pediatric population, clonal neoplastic processes are responsible for acute disseminated forms (Letterer-Siwe syndrome) or multifocal forms (Syndrome Hand-Schuller-Christian),and both have an unfavorable prognosis.

In adults, LCH may affect one or several organs in a multisystemic disease. The pulmonary form is usually sporadic and occurs almost exclusively in smokers, with smoking history of at least 20 pack-years. It is believed that, unlike systemic forms, exposure to tobacco antigens generates a polyclonal response with recruitment and accumulation of Langerhans cells throughout the interstitium of small airways.

LCH is a rare condition. The prevalence of 3.4% found in a series of 502 surgical lung biopsies may be underestimated, because many patients may improve spontaneously or may be asymptomatic and diagnosis is defined based on radiological findings. The main clinical features are cough, dyspnea and respiratory failure. The mean age of diagnosis is between 20 and 40 years. Men and women are equally affected, which probably reflects the characteristics of smoking habits nowadays.

In the study of Vassallo and colleagues, median survival was 12.5 years between diagnosis and death in patients with LCH, which is lower than that described in general population. Among the predictors of poor prognosis In this study the predictors of worse prognosis include an obstructive pattern, air trapping and reduction in carbon monoxide diffusing capacity (DLCO) in pulmonary function tests.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • proven diagnosis of pulmonary Langerhans cell histiocytosis based on histopathological or clinical and radiological findings;

排除标准

  • lung transplantation
  • cognitive or musculoskeletal disorders that preclude exercise test;
  • severe or decompensated heart disease.

结局指标

主要结局

Maximal O2 uptake capacity (VO2 max)

时间窗: Baseline

Maximal O2 uptake capacity (VO2 max) during a cardiopulmonary exercise test (mL/kg/min)

次要结局

  • Six-minute walk distance(Baseline)
  • Velocity measurement of tricuspid regurgitant jet(Baseline)
  • Residual volume(Baseline)
  • Ejection fraction(Baseline)
  • Diffusing capacity for carbon monoxide(Baseline)
  • Residual volume/total lung capacity ratio(baseline)
  • Baseline Dyspnea Index(Baseline)
  • Short Form Health Survey (SF-36)(Baseline)
  • Inspiratory capacity(Baseline)
  • Forced expiratory volume in the first 1 second (FEV1)(baseline)
  • Six-minute walk test desaturation(Baseline)
  • Diameter of the cardiac chambers(Baseline)

研究者

发起方
InCor Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruno Guedes Baldi

phD

InCor Heart Institute

研究点 (1)

Loading locations...

相似试验